apoB Antibodies

Santa Cruz Biotechnology offers a broad range of apoB Antibodies for research in lipid metabolism and cardiovascular health. apoB Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Apolipoprotein B (apoB) is a key protein involved in the metabolism of lipoproteins, playing a crucial role in the transport of cholesterol and triglycerides in the bloodstream. The association of apolipoprotein B (apoB) with cardiovascular diseases makes it a critical biomarker for assessing cardiovascular risk. Understanding the function and regulation of apolipoprotein B (apoB) is essential for developing therapeutic strategies aimed at managing lipid disorders. Researchers worldwide rely on apolipoprotein B (apoB) monoclonal antibodies to advance their studies in cardiovascular health and disease prevention. Characterization of apolipoprotein B (apoB) continues to reveal new insights into its role in lipid homeostasis and disease progression. Santa Cruz Biotechnology monoclonal antibodies for apolipoprotein B (apoB) support breakthrough discoveries in cardiovascular research and therapeutic development.